Pharmaceuticals

Sustained Release Excipients Market Research: Growth Projections and Trends 2030

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sustained release excipients market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Sustained Release Excipients Market in 2026, and what figure is it projected to hit by 2030?

The sustained release excipients market size has experienced robust expansion in recent years. This market is projected to expand from $1.51 billion in 2025 to $1.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. Historically, this increase can be linked to factors such as the rising incidence of chronic diseases, a greater adoption of modified release tablets, progress in polymer chemistry, the proliferation of generic drug manufacturing, and the regulatory endorsement of sustained release formulations.

The sustained release excipients market is projected to experience robust expansion over the coming years, reaching $2.3 billion by 2030, with a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period is driven by several factors, including the increasing demand for long-acting injectables, the expansion of biologics and specialty drugs, growing investments in drug delivery research and development, the need for patient-centric formulations, and the increased presence of pharmaceutical manufacturing in emerging markets. Significant trends expected during this period encompass a rising demand for controlled drug delivery systems, the expanding utilization of polymers in sustained release formulations, a greater adoption of oral sustained release dosage forms, the development of microencapsulation and coacervation technologies, and a focus on improving patient compliance by reducing dosing frequency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

Which Drivers Are Affecting Market Participation In The Sustained Release Excipients Market?

The increasing need for personalized medicine is projected to boost the expansion of the sustained-release excipients market. Personalized medicine, also known as personalized care, involves medical experts analyzing a patient’s distinct genetic makeup, proteins, and other biological elements to deliver and manage tailored care through precision medicine. Within personalized medicine, sustained-release excipients are vital as they facilitate the creation of drug formulations specifically designed for the requirements of individual patients. As an illustration, in February 2024, data from the Personalised Medicine Coalition, a US-based hospital and health care organization, showed that in 2023, the FDA granted approval to 16 new personalized treatments for rare disease patients, marking an increase from 6 approvals in 2022. Consequently, the rising demand for personalized medicine is propelling the sustained-release excipients market forward.

What Segment Categories Are Covered In The Sustained Release Excipients Market?

The sustained release excipients market covered in this report is segmented –

1) By Product: Gelatin, Polymers, Minerals, Chitosan

2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration

3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:

1) By Gelatin: Type A Gelatin, Type B Gelatin

2) By Polymers: Natural Polymers, Synthetic Polymers

3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients

4) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Which Competitive Trends Are Impacting The Structure Of The Sustained Release Excipients Market?

Companies operating within the sustained release excipients market are increasingly focused on creating advanced solutions, such as multifunctional polymer platforms, to improve drug formulation efficiency, decrease delivery time, and facilitate controlled-release profiles. These multifunctional polymer platforms refer to excipients capable of enabling immediate, delayed, and sustained drug release, while also being compatible with formulation technologies like hot melt extrusion and solubility-enhancing spray drying. For example, in September 2024, Evonik, a Germany-based company, commenced operations at a new spray drying facility located at its Darmstadt site, dedicated to EUDRAGIT polymers. This facility is designed to boost production capacity, shorten delivery times, and fully integrate with existing production networks. It incorporates green electricity and steam from local waste incineration, which is expected to reduce CO2 emissions by over 1,000 tons annually. Operating under IPEC-GMP pharmaceutical guidelines and directly linked to the production of aqueous dispersions, the facility minimizes transportation requirements and streamlines the supply chain. The polymers manufactured there support immediate, delayed, and sustained release formulations, thereby solidifying Evonik’s global leadership in oral drug delivery solutions and enhancing its capability to efficiently support innovative pharmaceutical development.

Which Leading Companies Dominate The Sustained Release Excipients Market Share?

Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

How Does The Sustained Release Excipients Market Perform Across Major Global Regions?

North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sustained Release Excipients Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp

Browse Through More Reports Similar to the Global Sustained Release Excipients Market 2026, By The Business Research Company

Sustained Release Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Controlled Release Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795